Dr. Matthew S. Gentry's lab at the University of Florida focuses on how brain metabolism and glycogen storage are linked to neurological diseases, particularly Lafora disease and Alzheimer's disease. They study how abnormal aggregates of glycogen, known as polyglucosan bodies, contribute to disease progression and seek to develop potential therapies to address these conditions. The research aims to understand the cellular mechanisms behind these diseases and to explore therapeutic options to restore healthy brain function.

Dr. Zhipeng Li's lab at the University of Florida focuses on understanding the role of the trace element selenium in cellular health. Their research investigates how selenium metabolism affects cell survival and how cells adapt to low selenium levels, which is essential for maintaining redox balance and preventing cell death. By developing a unique low-selenium cell system, the lab aims to uncover mechanisms related to selenium regulation and its implications for diseases related to selenium dysregulation.

Dr. Matthew E. Merritt's lab at the University of Florida focuses on developing advanced imaging techniques to study brain metabolism, particularly how the brain utilizes glucose for energy. The team is investigating new magnetic resonance imaging methods that can enhance the detection of metabolic processes in the brain, which could lead to better understanding and diagnosis of neurological diseases, including cancer. Their research aims to provide safer, non-invasive imaging alternatives to current methods, enabling repeated studies in various populations.

Dr. Donald G. Phinney's lab focuses on improving the therapeutic applications of mesenchymal stem cells (MSCs) for various human diseases. By developing a Clinical Indications Prediction (CLIP) scale, the lab aims to enhance the understanding of how donor characteristics and manufacturing processes affect the potency of MSCs. This research is crucial in creating tailored MSC therapies that yield better patient outcomes.

Dr. Ramon C. Sun's lab at the University of Florida investigates the role of glycogen metabolism in various cancers and Alzheimer's disease. The team is particularly focused on understanding how glycogen influences tumor growth and treatment responses, aiming to develop new diagnostic and therapeutic strategies for Ewing's Sarcoma and lung adenocarcinoma. Their research employs advanced techniques like mass spectrometry imaging to study glycogen and complex carbohydrates in tumor samples, which could lead to personalized patient therapies.

Dr. Thomas J. Kodadek's research lab at the University of Florida focuses on discovering new small molecules that can interact with proteins, particularly those involved in the Ubiquitin Proteasome System (UPS). His team employs cutting-edge DNA-encoded library technology to identify compounds that can manipulate protein degradation pathways, which are essential for maintaining cellular health. Their innovative approach aims to develop drugs that can enhance the body's ability to remove damaged or misfolded proteins, thereby opening new avenues for treating diseases linked to aging and degeneration.

Dr. Mingyi Xie's lab at the University of Florida focuses on understanding how specific small RNAs called microRNAs are regulated in T-cell acute lymphoblastic leukemia (T-ALL). They are investigating a novel mechanism where mRNA can degrade microRNAs, which could lead to new strategies for treating leukemia and overcoming resistance to current therapies. The lab's work could provide insights into gene regulation and potential therapeutic approaches for cancer treatment.